In short. If the look has not been tested, the reversible option settles the question first. The trade in duration, and what each route commits the patient to afterwards.

Key points

  • The useful framing is not which is better but which order answers your question.
  • Test with the reversible option, judge it in photographs over several months, and only then decide whether the look should be held for years.
  • That order costs an extra step and removes the one risk this site keeps returning to.

Patients often choose the longer-lasting option because it lasts longer, treating duration as the measure of value. Whether that is right depends entirely on something neither substance can answer: whether you actually like the change. Where that is not yet established, the reversible option is the better first step, and the reasoning is not caution for its own sake.

What the reversible route settles

A hyaluronic-acid filler gives an immediate, precise result and can be dissolved. That means a patient can live with the change for some months, look at it in ordinary light and in photographs, and find out whether the fuller area is one they want held. It is the only way to test the question. No assessment, however careful, tells you how it feels to see a different face in the mirror, and every patient is a poor judge of that in advance.

What the non-reversible route assumes

A course of this substance assumes you already know. It arrives gradually, so the change is not abrupt, and it cannot be dissolved, so the assumption is not tested before it becomes expensive to be wrong. The patient who does well is the one who was already confident of the area and the amount. The patient who does badly is usually one who was told the result would be subtle, and who discovered at six months that they did not want it at all.

The sequence, not the comparison

The useful framing is not which is better but which order answers your question. Test with the reversible option, judge it in photographs over several months, and only then decide whether the look should be held for years. That order costs an extra step and removes the one risk this site keeps returning to.

What the trade actually is

A filler needs repeating sooner, and it does not change tissue quality, so it addresses less of the underlying concern. This substance asks for fewer visits across a longer period and produces a lasting change to the tissue itself. The price of the longer effect is the absence of any way to end it early. A patient choosing on duration alone has compared the smallest difference between the two.

Where the sequence gets skipped

  • A course booked at a first consultation for an area the patient has never seen treated.
  • A patient talked out of the reversible option on the grounds that it needs repeating.
  • A plan that does not say what happens if the result at six months is not wanted.

For a patient whose concern is diffuse tissue loss and who is certain of the area, the gradual material is a reasonable first choice, and the reversible step would add little. For a patient deciding, the reversible option is not a lesser treatment. It is the step that turns an assumption into a decision, and taking it costs some months and a further appointment.

Related reading

Frequently asked questions

Can I have a filler first and this substance later?

Often yes, and it is a sensible sequence where the immediate option settles what you want and the gradual one holds it. It has to be planned as one strategy rather than as two separate appointments, because what is placed first changes the baseline the second treatment is judged against.

Does starting with a filler mean committing to more appointments?

It can mean an extra step, and the step answers a question this substance cannot. A patient who has lived with a filler result for some months knows whether the change is one they want held, which is exactly what a first session of a non-dissolvable material assumes without proof.

Is the reversible option always the right one to start with?

No. Where the concern is genuinely diffuse and the patient is certain of what they want, starting with the gradual material is reasonable. The reversible option is the better first step where the look is unproven rather than where the concern is wrong for this substance.

Risks & Limitations

  • Irreversibility: there is no dissolving agent for this substance. A lump, an asymmetry or an over-correction is managed over time, with injected treatment, or occasionally by removal, and never switched off.
  • Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment and may need assessment and treatment rather than simply resolving.
  • Unevenness or over-correction. This substance is placed in an area that cannot be dissolved, so over-treatment is harder to correct than under-treatment.
  • Firmness under the skin in the first weeks, which is expected and usually settles, but does not always.
  • Infection or inflammation at an injection site, which needs prompt assessment rather than waiting.
  • Bruising, swelling, tenderness and occasional headache after treatment.
  • The volume visible on the day is the carrier rather than the effect. The result develops over months and cannot be judged early, it is not permanent, and the area continues to age.

When to Seek Care

  • A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
  • Redness, warmth, swelling or pus at an injection site, or fever.
  • Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
  • Increasing pain, or pain out of proportion to the injection.
  • Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.

References & Further Reading

  • American Academy of Dermatology (AAD) — injectable and skin safety information
  • American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
  • U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
  • National Medical Products Administration (NMPA, China) — approved product status
  • Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.